[Collections of human biological resources for research purposes: from regulations to the need of a guide of good collection practices]. / Les collections de ressources biologiques humaines pour la recherche : de la réglementation à la mise en place d'un guide de bonnes pratiques du collectionneur.

PURPOSE: In France, collections of human biological resources are regulated by the "Bioethics Law", currently in revision. Hence, we analyse the regulatory and ethical issues of these practices in the context of scientific research. The ultimate aim of such collections is to improve biological and medical knowledge. CURRENT KNOWLEDGE AND KEY POINTS: We think that the French regulatory system is quite complicated and non-explicit for "collection holders". The multiplicity of legal texts concerning this activity has made their application difficult, especially in the absence of application decrees. The project amending the actual law has clarified the legal status of collections but it did not shed light on the status of human body detached parts. Furthermore, the text is still very far from the international bioethical recommendations, and does not reflect the actual collection's implementation. FUTURE PROSPECTS AND PROJECTS: The establishment of a guideline of Good Collection Practices, based on clear principles, should help to simplify the situation, especially when it is imbedded in the regulation and linked to control procedures. It would allow a balance between collective interests and the protection of individuals, taking into account of the international highly competitive scientific and economical constraints. The major issue is to preserve and to perpetuate the existing and future collections because of their precious value as an important tool for biomedical knowledge. The efficiency of a regulation depends on its legibility and accessibility, two requirements that seem to determine the acceptance of the regulatory tool and its application allowing subsequently to reach fairness in proceedings.

[Associations of patients and tissue banks]. / Les associations de malades et les banques de tissus.

Research dealing with tissue is more important to day than ever. Techniques of molecular genetics have indeed permitted the identification of a large number of new proteins that have now to be localised in the tissue and in the cell, in health and disease. This step has to be made in order to elaborate the adequate animal models in which new therapeutics can be tested. In France, however, human tissue samples have become difficult to obtain. Many factors contributed to this situation. Autopsies are now exceptionally performed. Doctors feel confident in their diagnosis and express rarely the need to control it. Families are opposed to post mortem more strongly than before, especially when the reasons for performing it can not be explained before the death of the patient. French law now makes the explicit consent of the patient mandatory before any research. This practically limits all post mortem investigations to those that had been planned before death. The possibility of giving tissue post mortem to allow research has to be publicised, particularly by associations of patients. The organisation that should manage to collect and store the samples at a large scale and over the whole country is lacking. Its structure is still discussed: should it be supported by the state itself, by private funding, possibly by the associations of patients themselves? Patients Associations are ready to play a crucial role: they realised that the present system was inefficient, they are presently trying to organise tissue banks; they will finally have to explain to their members why they should care for research, how they could help and how they will have to accept the absence of immediate spectacular results.

Calcium phosphate deposits in domes of human pancreatic adenocarcinoma (Capan-1) cell cultures.

Human pancreatic cells of the Capan-1 line form domes in culture during the stationary growth stage. The domes are thought to be a result of the transport of water and electrolytes by the Capan-1 cells. In older Capan-1 cultures, the epithelial sheets formed thickenings from several layers of cells of which the outermost ones were joined by tight type junctions. In the intracellular space, deposits of insoluble calcium salts were observed. Culture of Capan-1 cells in the presence of fibroblasts prolonged survival of the cultures with intact domes for more than 80 days. The Capan-1 cells proliferated forming multilayers and closed cavities which we called super-domes. X-ray spectrometry and electron diffraction analysis showed that the abundant deposits inside these cavities consisted of calcium phosphate in an apatite structure. The number of these deposits increased with time in culture, and they appeared to be formed at the sites of contact with an extracellular matrix consisting of cell debris. Deposits were not observed within the culture medium. Cells from domes were stained cytochemically for ATPases and alkaline phosphatases and examined by light and electron microscopy. The Capan-1 cells surrounding the domes were differentiated, polarized cells containing placental type alkaline phosphatases on their apical membranes and Ca2(+)-ATPases on their basolateral membranes. These enzymes were thought to play a role in the accumulation of phosphate and Ca2+ ions in the dome cavities, which then formed crystals in the presence of organic compounds produced by lysis of cells of the deepest layers of the super-domes. The crystals of hydroxyapatite observed in standard Capan-1 cell cultures and those cocultured with fibroblasts were assumed to be a result of transepithelial transport of Ca2+ and phosphate ions by these cells.